Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19

This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.

Detalles Bibliográficos
Autores principales: Close, Ryan M., Jones, T. Shaifer, Jentoft, Christopher, McAuley, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456379/
https://www.ncbi.nlm.nih.gov/pubmed/34546375
http://dx.doi.org/10.1001/jamanetworkopen.2021.25866
Descripción
Sumario:This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.

Ejemplares similares